2m 2m 2m 2m 2m 2m 2m
SPERO THERAPETCS (SPRO)
NASDAQ
$2.88+$0.08 (+3.00%)
Price as of Jun 03, 2026 7:57 PM EDT- $163.9MMarket Cap
- 7.20%1-Year Change
- BiotechnologyIndustry
SPERO THERAPETCS (SPRO)
$2.88+$0.08 (+3.00%)
SPRO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.80 | ||
Change | $0.00 (0.00%) | ||
Open | $2.86 | ||
High | $2.87 | ||
Low | $2.77 | ||
Previous Close | $2.83 | ||
Volume | 775,490 | ||
30-Day Average Volume | 749,241 | ||
1-Week Change | -1.05% | ||
1-Month Change | 14.11% | ||
1-Year Change | 7.20% | ||
3-Year Change | 55.49% | ||
5-Year Change | -80.79% | ||
Fundamentals | |||
Shares Outstanding | 57.9M | ||
Total Assets | $59.0M | ||
Market Cap | $163.9M | ||
Enterprise Value | $107.8M | ||
Period: QTR TTM FY | |||
Revenue | $258,000.00 | ||
Net Income | -$7.2M | ||
Free Cash Flow | $15.9M | ||
EBIT | -$7.2M | ||
EBITDA | -$7.2M | ||
Net Working Capital | $52.1M | ||
EPS | -$0.13 | ||
Enterprise Value/EBITDA | -15 | ||
Enterprise Value/Revenue | 418 | ||
P/B | 3 | ||
P/E | -22 | ||
PEG | 0 | ||
Price/Free Cash Flow | 10 | ||
Price/Operating Cash Flow | 10 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue